MARKET

STLN

STLN

Starling Oncology, Inc.
NASDAQ
4.990
-0.040
-0.80%
After Hours: 6.17 +1.18 +23.65% 19:59 08/06 EDT
OPEN
4.950
PREV CLOSE
5.03
HIGH
5.05
LOW
4.850
VOLUME
2.02M
TURNOVER
--
52 WEEK HIGH
6.67
52 WEEK LOW
2.320
MARKET CAP
498.91M
P/E (TTM)
-13.2960
1D
5D
1M
3M
1Y
5Y
1D
The Oncology Institute GAAP EPS of -$0.08 misses by $0.02, revenue of $161.28M beats by $6.08M
Seeking Alpha · 7h ago
Press Release: Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
Dow Jones · 8h ago
Analyst Maintains Buy on Starling Oncology Rebrand, Keeps $7 Price Target Unchanged
TipRanks · 3d ago
Starling Oncology Unveils New Nasdaq Ticker Symbol
TipRanks · 3d ago
Oncology Institute rebrands as Starling Oncology
TipRanks · 3d ago
ONCOLOGY INSTITUTE - COMMON STOCK TO TRADE UNDER TICKER STLN ON NASDAQ EFFECTIVE AUGUST 4, 2026
Reuters · 3d ago
Oncology Institute to trade on Nasdaq as STLN from Aug. 4, replacing TOI
PUBT · 3d ago
Weekly Report: what happened at TOI last week (0727-0731)?
Weekly Report · 3d ago
More
About STLN
Starling Oncology, Inc., formerly The Oncology Institute, Inc., is advancing oncology by delivering specialized, value-based cancer care in the community setting. The Company offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with oncology organizations. Its critical services include cancer treatment and infusion centers, in-house dispensary, lab testing, outpatient blood transfusion, financial counseling, end-of-life counseling and comprehensive clinical trials. It treats many forms of cancer, including Acute lymphoblastic leukemia; Acute myeloid leukemia; Bladder cancer; Bone cancer; Brain cancer; Cervical cancer; Choriocarcinoma; Chronic lymphocytic leukemia (CLL); Chronic myeloid leukemia (CML); Skin cancer, and others. It operates over 100 clinics and affiliate locations across multiple states.

Webull offers Starling Oncology, Inc. stock information, including NASDAQ: STLN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STLN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STLN stock methods without spending real money on the virtual paper trading platform.